$250K
Pusingan Pembiayaan Startup Bioteknologi
Pusingan pembiayaan startup terkini daripada pemfailan Form D kepada SEC dan berita teknologi. 296 pembiayaan direkodkan, dikemas kini 15 Okt 2026.
Lihat semua 2,236AI & Data 200Ejen & Pembantu AI 30Infrastruktur AI 11Kecerdasan Buatan 191Data & Analitik 10Perisian B2B 1,130Keselamatan Siber 25Infrastruktur Awan 25Produktiviti 9Jualan & Pemasaran 5Sumber Manusia & Pengambilan 8Undang-undang & Pematuhan 9Fintech 168Pembayaran 10Perbankan & Pinjaman 80Pelaburan 6Insurans 53Kripto & Web3 6Perakaunan & Kewangan 7Kesihatan 558Kesihatan Digital 15Peranti Perubatan 28Kesejahteraan & Kesihatan Mental 15Deep Tech 360Robotik & Dron 38Pembuatan & Semikonduktor 125Aeroangkasa & Pertahanan 26Iklim & Tenaga 117Logistik 10Mobiliti & Automotif 11Makanan & Pertanian 35Hartanah & Pembinaan 18IoT & Telekomunikasi 13Pengguna & Perdagangan 79E-dagang 34Sosial & Komuniti 5Permainan 5Media & Hiburan 13Pendidikan 9Pelancongan 8
$500KDebt
$55MEquity
$1.25MDebt
InSitu Biologics
Pemfailan Form D: $1.25M terjual daripada tawaran $3.38M · 1 pelabur · pemfailan pindaan
$2.96MEquity
Hypercell Technologies
Pemfailan Form D: $2.96M terjual daripada tawaran $4.42M · 14 pelabur
$7.5MOptions
$1.01MEquity
$1.23MEquity
$49.8MEquity + debt
Curadel Surgical Innovations
Pemfailan Form D: $49.8M terjual daripada tawaran $57.5M · 39 pelabur
$66.1KEquity
$560KDebt
$2.63MEquity
$185KDebt
€16MSeed
Undecimal Bio
Undecimal Bio lands €16 million to develop targeted RNA medicines beyond the liver
$1.2MEquity + debt
$3MEquity
$167KEquity
$20M
Polyphron
Polyphron Raises $20M to Predict Drug Toxicity in Human Tissue Before Clinical Trials
$1.2MDebt
$4.35MEquity
GelSana Therapeutics
Pemfailan Form D: $4.35M terjual daripada tawaran $4.93M · 33 pelabur · pemfailan pindaan
$10.1MEquity
$1.5MEquity
$388KEquity
Rheos Medical
Pemfailan Form D: $388K terjual daripada tawaran $2M · 9 pelabur · pemfailan pindaan
$388KEquity
$100KEquity
$7MEquity
$233KEquity
€3.8MSeed
Cori Clinical
London’s Cori Clinical raises €3.8 million to accelerate clinical trials and reduce delays
$75MSeries B
Multiply Labs
Multiply Labs raises $75M to optimize pharmaceutical manufacturing with robots
$3.32MEquity + debt
$200KSAFE
€23.2MSeries B
WhiteLab Genomics
Paris-based WhiteLab Genomics raises €23.2 million to accelerate AI-driven genomic medicine development
$8.97MOptions
$16.1MEquity
Eikonoklastes Therapeutics
Pemfailan Form D: $16.1M terjual daripada tawaran $18.6M · 15 pelabur · pemfailan pindaan
$35.1MEquity
$900KEquity
$2.5MSAFE
$15.7MEquity
Altay Therapeutics
Pemfailan Form D: $15.7M terjual daripada tawaran $45.1M · 19 pelabur
$100KOptions
$352MEquity